Clinical Trials Browser

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00513071 2018-04-19

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

28 enrolled 9 charts

Genitourinary

Prostatic Neoplasms

NCT02085603 2018-04-13

SarCaBon

Phase 2 Completed

12 enrolled

Tumor-Agnostic

Neoplasms

NCT00528645 2017-12-07

AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Completed

23 enrolled 7 charts

Thoracic

Pleural Effusion, Malignant, Small Cell Lung Carcinoma

NCT00718809 2015-06-10

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Phase 2 Terminated

21 enrolled 13 charts

Thoracic

Thymoma

NCT01267266 2015-04-01

Saracatinib in Treating Patients With Prostate Cancer

Phase 2 Terminated

31 enrolled 6 charts

Genitourinary

Prostatic Neoplasms

NCT00669019 2014-05-21

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

23 enrolled 6 charts

Dermatologic

Melanoma

NCT00513435 2014-04-30

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Completed

9 enrolled 8 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

NCT00559507 2014-04-30

Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery

Phase 2 Completed

12 enrolled 8 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00558272 2013-05-27

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Phase 2 Completed

139 enrolled 23 charts

BreastGenitourinarySarcoma

Bone Diseases, Bone Neoplasms, Breast Neoplasms, Prostatic Neoplasms

NCT00610714 2012-12-18

OVERT-1

Phase 2 Completed

211 enrolled 12 charts

Gynecologic

Neoplasms, Ovarian Neoplasms